A Diagnostic and Therapeutic Scheme for a Solitary Cysticercus Granuloma
Neurol 75:2236-2245, Singh,G.,et al, 2010
Neurocysticercosis Uncovered by Single-Dose Albendazole
NEJM 356:1277-1278, Garcia,H.H.,et al, 2007
Tapeworms and Seizures--Treatment and Prevention
NEJM 350:215-217, Maguire,J.H., 2004
A Trial of Antiparasitic Treatment to Reduce the Rate of Seizures Due to Cerebral Cysticercosis
NEJM 350:249-258,215,280, Garcia,H.H.,et al, 2004
Long-term Prognosis in Patients with Vasculopathic Sixth Nerve Palsy
Am J Ophthalmol 134:81-84, Sanders,S.K.,et al, 2002
Single-Day Praziquantel Versus 1-week Albendazole for Neurocysticercosis
Neurol 52:1079-1081, DelBrutto,O.H.,et al, 1999
Large Cerebral Infarction During Praziquantel Therapy in Neurocysticercosis
Stroke 28:211-213, Bang,O.Y.,et al, 1997
Is the Course of Neurocysticercosis Modified by Treatment with Anthelmintic Agents
Arch Int Med 157:128-129, DelBrutto,O.H., 1997
Albendazole Therapy for Neurocysticercosis:A Prospective Double-Blind Trial Comparing 7 vs 14 Days of Treatment
Neurol 48:1421-1427, Garcia,H.H.,et al, 1997
Single-Day Praziquantel Therapy for Neurocysticercosis
NEJM 334:125, Corona,T.,et al, 1996
Is the Course of Neurocysticercosis Modified by Treatment with Antihelminthic Agents
Arch Int Med 155:1982-1988, Carpio,A.,et al, 1995
Medical Treatment of Cysticercosis-Ineffective
Arch Neurol 52:101-102, 1041995., Kramer,L.D., 1995
Medical Treatment of Cysticercosis-Effective
Arch Neurol 52:102-104, DelBrutto,O.H., 1995
Clinical and Immunologic Follow-up Study of Patients with Neurocysticercosis after Treatment with Praziquantel
Neurol 45:532-538, Rolfs,A.,et al, 1995
Albendazole Therapy for Persistent, Solitary Cysticercus Granulomas in Patients with Seizures
Neurol 43:1238-1240, Rajshekhar,V., 1993
The Use of Albendazole in Patients with Single Lesions Enhanced on Contrast CT
NEJM 328:356-357, DelBrutto,O.H., 1993
Albendazole Therapy for Giant Subarachnoid Cysticerci
Arch Neurol 49:535-538, DelBrutto,O.H.,et al, 1992
Therapy for Neurocysticercosis
Arch Neurol 49:290-294, Takayanagui,O.M.&Jardim,E., 1992
Total Recovery of Visual Function after Treatment for Cerebral Cysticercosis
NEJM 324:1137-1139, Santoyo,H.,et al, 1991
Treatment of Neurocysticercosis:Is Praziquantel the New Hope?
Lancet 1:262-263, Moodley,M.&Moosa,A., 1989
Drugs Five Years Later:Praziquantel
Ann Int Med 110:290-296, King,C.H.&Mahmoud,A.A.F., 1989
Neurocysticercosis:Short Course of Treatment with Albendazole
Arch Neurol 46:1231-1236, Alarcon,F.,et al, 1989
Short Course of Albendazole Therapy for Neurocysticercosis
Arch Neurol 45:1130-1133, Sotelo,J.,et al, 1988
Albendazole vs Praziquantel for Therapy for Neurocysticercosis, A Controlled Trial
Arch Neurol 45:532-534, Sotelo,J.,et al, 1988
Praziquantel in the Treatment of Neurocysticercosis:Long-Term Follow-Up
Neurol 35:752-755, Sotelo,J.,et al, 1985
Endovascular Therapy for Acute Vertebrobasilar Occlusion (VERITAS): A Systematic Review and Individual Patient Data Meta-Analysis
Lancet 405:61-69, Nogueira,R.G.,et al, 2025
Rocky Mountain Spotted Fever Encephalitis and "Starry Sky" Pattern on MRI, A Case Report
Neurologist 30:34-38, Mikhaiel,J.P.,et al, 2025
Spectrum of Intracranial Hemorrhages in Cerebral Venous Thrombosis, A Pictorial Case Series and Review of Pathophysiology and Management
Neurologist 30:45-51, Jha,S.,et al, 2025
Acute Postradiation Lumbosacral Plexopathy
Neurol 103:e209972, Koropouli,E.,et al, 2024
Prediction of Severe Baseline Asymptomatic Carotid Stenosis and Subsequent Risk of Stroke and Cardiovascular Disease
Stroke 55:2632-2640, Poorthuis,M.H.F.,et al, 2024
Cerebrovascular Events in Patients Undergoing Transcatheter Aortic Valve Replacement:A Review
Stroke 55:2754-2764, Patel,K.P.,et al, 2024
Optimal Timing of Anticoagulation after Acute Ischaemic Stroke with Atrial Fibrillation (OPTIMAS): A Multicentre, Blinded-Endpoint, Phase 4, Randomised Controlled Trial
Lancet 404:1731-1741, Werring,D.J.,et al, 2024
Diagnostic MRI Score to Differentiate Susac Syndrome from Primary Angiitis of the Central Nervous System and Multiple Sclerosis
Ann Neurol 96:846-854, Marrodan,M.,et al, 2024
Angioedema Following Tenecteplase for Acute Ischemic Stroke
Stroke 55:e242-e244, Dellabella,A., 2024
Middle Meningeal Artery Embolisation for Nonacute Subdural Hematoma
NEJM 391:1901-1912, Ni,J.L.W.,et al, 2024
Adjunctive Middle Meningeal Artery Embolization for Subdural Hematoma
NEJM 391:1890-1900, Davies,J.M.,et al, 2024
Chronic Immunotherapy for Myasthenia Gravis
www.UptoDate.Com, Bird,S.J., 2024
Efficacy and Safety of Erenumab for Nonopioid Medication Overuse Headache in Chronic Migraine, A Phase 4, Randomized, Placebo-Controlled Trial
JAMA Neurol 81:1140-1149, Tepper,S.J.,et al, 2024
Left Atrial Appendage Occlusion vs Standard of Care After Ischemic Stroke Despite Anticoagulation
JAMA Neurol 81:1150-1158, Maarse,M.,et al, 2024
A 65-Year-Old Woman with Isolated Macroglossia as the Initial Presentation of a Rare Disease
Neurol 103:e210070, Lara,C.,et al, 2024
Reversible Cerebral Atrophy and Substantia Nigra Changes after Vitamin B12 Treatment in Infantile Tremor Syndrome
Neurol 103:e210076, Singh,R.,et al, 2024
2024 Guide for the Primary Prevention of Stroke:A Guideline From the American Heart Association/American Stroke Association
Stroke 55:e344-e424, Bushnell,C.,et al, 2024
Clinicopathologic Conference, Psychotic Disorder Due to a General Medical Condition (postictal psychosis)
NEJM 391:2036-2046, Case 37-2024, 2024
Tranexamic Acid Within 4.5 Hours of Intracerebral Hemorrhage With the CTA Spot Sign, Systematic Review and Individual Patient Meta-Analysis
Neurol 103:e210104, Yassi,N.,et al, 2024
Clinicopathologic Conference, Infective Endocarditis Due to Haemophilus Parainfluenza
NEJM 391:2148-2157, Case 38-2024, 2024
Safety and Efficacy of Staged, Bilateral Focused Ultrasound Thalamotomy in Essential Tremor, An Open-Label Clinical Trial
JAMA Neurol 81:939-946, Kaplitt,M.G.,et al, 2024
Miyazaki Syndrome as a Complication of Shunt Drainage
Ann Neurol 96:1230-1231, vanLanen,R.H.G.J., et al, 2024
Clinicopathologic Conference, Cryptococcal Meningoencephalitis
NEJM 391:2361-2369, Case 40-2024, 2024
Effect of IV Thrombolysis With Alteplase in Patients with Vessel Occlusion in the WAKE-UP Trial
Neurol 104:e209871, Galinovic,I.,et al, 2024